Curcumin-stabilized silver nanoparticles target the Helicobacter pylori-tumor interface in gastric cancer Authors: Komal Attri, Deepinder Sharda, Isha Tanwar, Priyanshu Gautam, Diptiman Choudhury Published: 2026 ABSTRACT Gastric cancer remains a major global health burden, ranking among the leading causes of cancer-related mortality worldwide. Chronic infection with Helicobacter pylori is a well-established etiological factor, promoting sustained gastric inflammation, epithelial transformation, and tumor progression through modulation of the gastric microenvironment. Therapeutic strategies that simultaneously target microbial virulence and tumor cell survival remain limited. In this study, we developed curcumin-stabilized silver nanoparticles (AgNPs) as a dual-functional nanoformulation designed to modulate the tumor-associated microbiome while exerting direct anti-cancer effects. The nanoparticles were chemically synthesized with a controlled diameter of 15 ± 2 nm, enabling enhanced surface reactivity and biological interaction. Antimicrobial evaluation revealed potent activity against H. pylori, with an IC50 of 3.86 µg/mL. Furthermore, AgNPs significantly inhibited urease activity—a critical virulence determinant for gastric colonization—achieving 80.46 ± 1.15% inhibition at 160 µg/mL. Broad-spectrum antibacterial efficacy was also observed against other tested strains, indicating potential for reshaping the tumor microbiome. Cytotoxicity assessment in AGS human gastric adenocarcinoma cells demonstrated substantial anti-proliferative activity, with 73.99 ± 2.13% reduction in cell viability. The integration of curcumin, a bioactive polyphenol with established anti-inflammatory and anti-neoplastic properties, with silver nanoparticles provides a synergistic platform targeting both microbial and tumor components of gastric carcinogenesis. Collectively, these findings highlight AgNPs as a promising microbiome-directed nanotherapeutic strategy for gastric cancer management, warranting further mechanistic and translational investigation.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-54162-3. Introduction Gastric cancer remains a major global health burden and ranks among the leading causes of cancer-related mortality worldwide. Despite advances in surgical techniques, chemotherapy, and immunotherapy, prognosis remains poor in advanced disease, particularly in high-incidence regions of East Asia, Eastern Europe, and parts of South America. A dominant etiological driver of gastric carcinogenesis is persistent infection with Helicobacter pylori, a Gram-negative, spiral-shaped, microaerophilic bacterium uniquely adapted to colonize the human gastric mucosa1–4. The World Health Organization classifies H. pylori as a Group I carcinogen due to its unequivocal association with gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma5. Recent global analyses estimate that more than half of the world’s population harbors H. pylori, with infection prevalence exceeding 60% in several developing regions3,4. In 2020 alone, gastric cancer accounted for approximately 769,000 deaths and over 1.09 million new diagnoses, underscoring the magnitude of this infection-driven malignancy1. The carcinogenic cascade initiated by H. pylori is mechanistically complex and temporally progressive. Chronic colonization induces sustained gastritis, leading to atrophic gastritis, intestinal metaplasia, dysplasia, and eventually adenocarcinoma. A central survival mechanism of the bacterium lies in its robust urease activity, which catalyzes the hydrolysis of urea into ammonia and carbon dioxide, thereby neutralizing gastric acidity and enabling persistence within an otherwise hostile environment6. Beyond metabolic adaptation, virulence determinants including CagA and VacA disrupt epithelial integrity, alter intracellular signaling, and promote genomic instability. Adhesion-related factors such as BabA, SabA, OipA, DupA, and FlaA further facilitate colonization and inflammatory amplification. Sustained inflammation generates oxidative and nitrosative stress, promoting DNA damage and epigenetic alterations that potentiate malignant transformation1,7. While eradication therapy has reduced infection prevalence in some regions, the success of standard triple and quadruple antibiotic regimens is increasingly undermined by antimicrobial resistance8. Clarithromycin resistance now exceeds 40% in parts of Southern and Eastern Europe and reaches 30–60% in East Asia9. Metronidazole resistance approaches 60% in several geographic settings, and levofloxacin resistance continues to rise10. Reports from India indicate metronidazole resistance in up to 90% of isolates and clarithromycin resistance approaching 25%11,12. These patterns are not merely microbiological concerns but carry significant clinical and economic consequences. Treatment failure necessitates repeated therapeutic cycles, prolonged proton pump inhibitor exposure, increased endoscopic surveillance, and higher risk of progression to gastric malignancy. In low- and middle-income countries, the cost burden of repeated eradication attempts and advanced cancer care exerts disproportionate strain on healthcare systems. Consequently, there is a pressing need for alternative antimicrobial strategies that bypass conventional resistance pathways. Emerging evidence suggests that gastric tumorigenesis is not solely driven by epithelial mutations but is significantly shaped by the tumor-associated microbiome. The tumor microenvironment (TME) comprises a dynamic interplay between immune cells, stromal components, microbial communities, and cancer cells. Microbial dysbiosis influences immune evasion, cytokine signaling, angiogenesis, and metastatic potential13. The persistence of H. pylori within this microenvironment sustains inflammatory signaling pathways such as NF-κB and PI3K/Akt, thereby reinforcing pro-survival and proliferative networks14,15. Thus, targeting microbial drivers may represent a strategic upstream intervention in gastric oncogenesis. Nanotechnology offers a compelling platform to address these intertwined microbial and oncologic processes. Nanoparticles possess unique physicochemical properties, including high surface area-to-volume ratios, tunable surface chemistry, and enhanced mucosal penetration capabilities, enabling site-specific delivery and multimodal therapeutic action16,17. Metal nanoparticles, in particular, have demonstrated promise in antimicrobial and anticancer applications due to their intrinsic catalytic and redox-active properties18. Among these, silver nanoparticles (AgNPs) exhibit broad-spectrum antibacterial activity, wound healing19 and are capable of generating reactive oxygen species (ROS), disrupting membrane integrity, and interfering with enzyme function20–22 and anti-cancer potential when combined with different drugs23–25. Silver ions are hypothesized to interact with the nickel-containing active site of H. pylori urease, thereby impairing acid-neutralizing capacity and compromising bacterial survival26,27. In parallel, curcumin, a polyphenolic compound derived from Curcuma longa, exhibits anti-inflammatory, antioxidant, antimicrobial, and anticancer properties. It modulates NF-κB signaling, suppresses pro-inflammatory cytokines such as TNF-α and IL-6, and induces apoptosis through regulation of the PI3K/Akt/mTOR and MAPK pathways15. Curcumin also demonstrates inhibitory activity against H. pylori, including suppression of urease activity and downregulation of virulence factors such as CagA28. However, its clinical translation is hindered by poor solubility and limited bioavailability. Integrating curcumin with silver nanoparticles presents a rational nanomaterial strategy to overcome these limitations. Curcumin can function both as a stabilizing ligand and as a bioactive component, potentially enhancing nanoparticle biocompatibility and therapeutic synergy22,29. Such hybrid nanoformulations may exert multi-targeted effects: oxidative disruption of bacterial membranes, inhibition of urease activity, suppression of inflammatory signaling, and induction of tumor cell apoptosis. Importantly, nanoparticle-mediated mechanisms rely on physical–chemical interactions rather than single molecular targets, reducing the probability of resistance development30. Recent advances in nano-enabled antimicrobial systems emphasize the importance of mucosal retention, controlled ion release, and selective cytotoxicity toward malignant cells while sparing normal tissues31,32. Designing nanoparticles within the 10–20 nm size range may enhance gastric mucosal penetration and cellular uptake, optimizing therapeutic impact. In the context of infection-driven cancer, such a platform offers a dual-intervention strategy: eliminating microbial carcinogenic drivers while directly targeting malignant cells. Based on this mechanistic and translational rationale, the present study explores curcumin-stabilized silver nanoparticles as a dual-functional nano-therapeutic platform aimed at controlling H. pylori infection and mitigating gastric cancer progression. By integrating antimicrobial, anti-inflammatory, and anticancer modalities within a single nanostructure, this work seeks to address the limitations of conventional antibiotic therapy and contribute to a microbiome-informed nanomedicine strategy for gastric oncology. Materials and methods Materials Silver nitrate (AgNO3), curcumin, sodium hydroxide (NaOH), and all other analytical-grade reagents were procured from Loba Chemie (India). Phosphate-buffered saline (PBS), Brain Heart Infusion (BHI) medium, Ham’s culture medium, Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS), and penicillin–streptomycin solution were obtained from HiMedia Laboratories (India). The human gastric adenocarcinoma cell line AGS was acquired from the National Centre for Cell Science (NCCS), India. The Helicobacter pylori strain ATCC 700,392 was used for antimicrobial investigations. All solutions were prepared using deionized water unless otherwise specified. Synthesis of silver nanoparticles Silver nanoparticles (AgNPs) were synthesized via a curcumin-mediated reduction method under alkaline conditions. Briefly, 10 mL of 5 mM aqueous AgNO3 solution was prepared and sonicated to ensure homogeneity. The pH was adjusted to 10 by dropwise addition of 20 mM NaOH under continuous stirring. Separately, 7 mg of curcumin was dissolved in 5 mL ethanol to obtain a clear solution. The curcumin solution was added dropwise to the alkaline AgNO3 solution under constant stirring (250 rpm). The reaction mixture was maintained at 50 °C for 24 h. A visible color transition from yellow to greenish-yellow indicated nanoparticle formation. The resulting nanoparticles were collected by centrifugation at 16,000 rpm for 20 min and washed three times with deionized water to remove unreacted species and residual salts. The purified pellet was re-dispersed in sterile water for subsequent characterization and biological assays. Study of particle size, morphology, and elemental analysis The hydrodynamic diameter and size distribution of the synthesized nanoparticles were determined using Dynamic Light Scattering (DLS) on a Malvern Zetasizer instrument. Measurements were conducted at room temperature using diluted aqueous dispersions. Surface morphology and structural characteristics were examined using Field Emission Scanning Electron Microscopy (FE-SEM) (Carl Zeiss Sigma 500). Elemental composition was analyzed using an integrated Energy Dispersive X-ray Spectroscopy (EDS) system (Bruker QUANTAX 200) operated under high vacuum. High-Resolution Transmission Electron Microscopy (HRTEM) was performed using a Talos F200S G2 (Thermo Scientific) to evaluate nanoparticle morphology and size distribution at the nanoscale. Prior to imaging, samples were centrifuged at 6,000 rpm for 10 min, washed thoroughly with deionized water to eliminate unbound ions and impurities, and deposited onto carbon-coated copper grids. Study of AgNPs interaction using spectroscopy UV–visible spectroscopy Optical properties and surface plasmon resonance (SPR) behavior were analyzed using a Shimadzu UV-2600 spectrophotometer. Spectra were recorded between 200 and 800 nm using a quartz cuvette with a 1 cm path length. Absorption profiles of AgNO3, curcumin, and synthesized AgNPs were compared. Fourier transform infrared (FTIR) spectroscopy FTIR analysis was performed using an Agilent Cary 600 series spectrophotometer to identify functional groups and assess curcumin–silver interactions. Samples were prepared using the potassium bromide (KBr) pellet method. Spectra were collected in the range of 400–4000 cm−1. Raman spectroscopy Raman spectra were recorded using a LabRAM HR confocal micro-Raman spectrometer equipped with 325 nm, 532 nm, and 785 nm excitation lasers. Dried nanoparticle samples were analyzed at room temperature. Spectra were collected over 200–2000 cm−1 with an acquisition time of 20 s per scan to improve signal-to-noise ratio. Characteristic vibrational bands were interpreted to confirm structural interactions within the nanoformulation. In vitro studies Cytotoxicity studies The cytotoxic potential of curcumin, AgNO3, doxorubicin and synthesized AgNPs was evaluated using the MTT assay in AGS (gastric adenocarcinoma) cells and HEK-293 cells (Human embryonic kidney cells). Cells were seeded in separate 96-well plates at a density of 1 × 10⁴ cells per well and incubated at 37 °C in a humidified atmosphere containing 5% CO2 until 75–80% confluence was achieved. Cells were treated with varying concentrations (10, 20, 40, 80, and 160 µg/mL) of curcumin, AgNO3, and AgNPs for 24 h. Following treatment, MTT reagent was added and incubated for 3 h at 37 °C. The supernatant was carefully removed, and 100 µL of dimethyl sulfoxide (DMSO) was added to dissolve the formazan crystals. Absorbance was measured at 570 nm using a microplate reader. Cell viability was calculated relative to untreated control cells and expressed as a percentage33. The inhibition percentage was calculated using the following equation: 1\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:\%\:inhibition=[1-\left(\frac{At}{Ac}\right)\:\times\:100\:\%$$\end{document} where the absorbance of the test substance is At, while the absorbance of the control solvent is Ac. Cell migration assay to assess anti-cancer potential The anti-migratory potential of curcumin, AgNO3, and synthesized AgNPs was evaluated using an in vitro scratch (wound healing) assay. AGS cells were seeded in 6-well plates and cultured in Ham’s medium without fetal bovine serum (FBS) to minimize proliferation-driven wound closure. Cells were maintained at 37 °C in a humidified incubator containing 5% CO2. Upon reaching 80–90% confluency, a uniform linear scratch was introduced across the cell monolayer using a sterile 10 µL pipette tip. Detached cells and debris were removed by gently washing the wells with phosphate-buffered saline (PBS). Fresh serum-free medium containing the respective test formulations (curcumin, AgNO3, or AgNPs) at predetermined concentrations was then added. Phase-contrast images were captured immediately after treatment (0 h) to document the initial wound width. Subsequent images were acquired at 6, 12, 24, 36, and 48 h using an inverted microscope under identical magnification settings. Scratch width was quantified at multiple random points along each wound area using image analysis software. The mean wound width for each time point was calculated from independent measurements within the same well. Percentage wound closure was determined relative to the initial wound width at 0 h. All experiments were performed in triplicate, and data were expressed as mean ± standard deviation34. Antibacterial Using minimum inhibitory concentration The antibacterial activity of the synthesized AgNPs was evaluated by determining the minimum inhibitory concentration (MIC) using the standard broth microdilution method in 96-well plates, following established protocols35. Helicobacter pylori (ATCC 700392) was cultured in Brain Heart Infusion (BHI) medium under microaerophilic conditions (5% O2, 10% CO2) at 37 °C. Acinetobacter calcoaceticus and Staphylococcus aureus were cultured in Luria–Bertani (LB) medium at 37 °C under aerobic conditions. After 24 h of incubation, bacterial suspensions were adjusted to approximately 108 CFU/mL using fresh medium. For the assay, 20 µL of bacterial suspension, 20 µL of test formulation (2.5, 5, 10, 20, 40, and 80 µg/mL), and 160 µL of the respective growth medium were added to each well to obtain a final volume of 200 µL. Wells containing bacterial suspension without treatment served as negative controls. Sterility controls containing only broth were included to ensure media integrity. Plates were incubated at 37 °C for 24 h under appropriate atmospheric conditions. Bacterial growth was quantified by measuring optical density at 600 nm (OD600) using a microplate reader. The MIC was defined as the lowest concentration of the formulation that inhibited visible bacterial growth. IC50 values were calculated from dose–response curves derived from OD measurements. All experiments were performed in triplicate. Agar well diffusion method The antibacterial activity of AgNPs was further validated using the agar well diffusion method36. Luria–Bertani agar plates were prepared for A. calcoaceticus and S. aureus, while BHI agar plates were used for H. pylori under microaerophilic conditions. Autoclaved agar media were poured into sterile Petri dishes and allowed to solidify. Bacterial cultures (50 µL, approximately 108 CFU/mL) were uniformly spread across the agar surface using sterile spreaders. Wells of 5 mm diameter were created using a sterile cork borer. Test formulations (curcumin, AgNO3, and AgNPs) at a concentration of 80 µg/mL were introduced into designated wells. Plates were incubated at 37 °C for 24 h under appropriate atmospheric conditions. Following incubation, zones of inhibition were measured in millimeters using a calibrated scale. Plates were maintained under light-protected conditions to prevent photo-degradation of curcumin-containing formulations. All assays were conducted in triplicate, and the mean zone diameter was reported. Anti-urease activity The inhibitory effect of synthesized formulations on H. pylori urease activity was assessed using a phenol red-based colorimetric assay as previously described. Briefly, H. pylori cultures were harvested by centrifugation, and the bacterial pellet was resuspended in lysis buffer. Cells were subjected to sonication (three cycles of 1 min each) with intermittent cooling on ice for 10 min to prevent thermal denaturation. The lysate was centrifuged to remove cellular debris, and the supernatant containing urease enzyme was collected. For the enzymatic assay, 20 µL of test compound was mixed with 50 µL of urease-containing lysate and incubated at 37 °C under 10% CO2 for 10 min. Subsequently, 0.1 M urea and 1 mM phenol red indicator were added, and the mixture was further incubated at 37 °C for 30 min. Urease activity was quantified by measuring absorbance at 570 nm using a microplate reader. Enzyme inhibition was calculated relative to untreated controls and expressed as percentage inhibition. All experiments were performed in triplicate, and data were expressed as mean ± standard deviation37. Based on the following equation, the inhibitory activity of compounds against H. pylori urease was determined: 2\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:Ia\left(\%\right)=\left[\right(Ac-As)/Ac]\times\:100\:$$\end{document} Ia = inhibitory activity, Ac = absorbance of the control, As = absorbance of the solution with samples. Molecular docking Molecular docking was conducted using AutoDock Vina (Version 1.5.7). The structure of curcumin (ligand) was obtained from the Drug Bank database in PDB format, and the three-dimensional structure of H. pylori urease (PDB ID: 1E9Y) in complex with AHA (acetohydroxamic acid) was obtained from the Protein Data Bank (RCSB PDB). The coordinates of the co-crystallised ligand (AHA) were used to define the docking grid centre, thereby setting the docking boundaries. A grid box with dimensions of 30 × 30 × 30 Å and centre coordinates of 127 × 129 × 86 (x, y, z) was used, with an exhaustiveness of 1038. To verify docking reliability, the co-crystallised ligand was extracted and re-docked into the active site, followed by calculation of the RMSD between the docked and co-crystallised ligands. The protein and ligand structures were converted to PDBQT format. Before conversion, Gasteiger charges were assigned to the ligands and rotatable bonds defined using AutoDock Tools. Water molecules, ions, and co-crystallised ligands were removed from the protein structure, followed by the addition of polar hydrogens and Kollman charges. The docking results were ranked according to binding energy, with more negative values indicating stronger binding affinity. Nine poses were generated, and the pose with the most negative binding energy was selected for further analysis. The protein–ligand interactions were visualised using BIOVIA Discovery Studio39. Determination of combination index (CI) for AgNO3 and Curcumin The combination index quantifies the impact of two distinct drugs when used together. This interaction may result in either synergistic or antagonistic effects. Calculating the drug combination index (CI) determines the extent of synergistic or antagonistic effects. A CI value less than 1 indicates synergism, where the combined administration of two drugs enhances each other’s activity. Conversely, a CI value exceeding 1 (CI > 1) demonstrates the antagonism and suggests that one drug inhibits the activity of the other drug. A CI value of 1 indicates that neither drug interferes with the other34. The CI was determined by computing and assessing the cell viability of AGS cells across different concentrations of AgNO3 and Curcumin, using Eq. (3) 3\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$CI = \frac{{(D)_{1} }}{{\left( {Dx} \right)_{1} }} + \frac{{\left( D \right)_{2} }}{{\left( {Dx} \right)_{2} }}$$\end{document} where 4\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:Dx=Dm\:{[fa/fu]}^{1/m}$$\end{document} Here, (D)1 and (D)2 give the concentration of AgNO3 and Curcumin. The concentrations (Dx)1 and (Dx)2, indicative of the median effective doses for the individual drugs, are determined through Eq. (4), where the affected and unaffected cell fractions in the median dose are denoted by fa and fu and are equal to 10(y−intercept)/m, where m represents the slope median in the median effect plot of log (D) vs. log (fa/fu) . Statistical analysis The data is given in terms of mean ± SD of a minimum of three independent experiments. MS Excel was used to perform statistical data analysis using the one-way ANOVA, and the calculation of the corresponding p-value was carried out to determine the statistical significance of the data. The data is considered significant when p-value < 0.05. Results and discussion Structural and compositional characterization of AgNPs Dynamic Light Scattering (DLS) analysis revealed a hydrodynamic diameter of approximately 123 nm for the synthesized silver nanoparticles (AgNPs) (Fig. 1a), indicating moderate colloidal dispersion in aqueous medium. The zeta potential comes out to be -18.6 eV. In contrast, High-Resolution Transmission Electron Microscopy (HR-TEM) demonstrated a significantly smaller core size, with nanoparticles exhibiting an average diameter of 15 ± 2 nm (Fig. 1b). The particles appeared predominantly spherical and well-dispersed, confirming successful nanoscale synthesis. The discrepancy between hydrodynamic and core size is attributable to solvation layers and surface-bound curcumin molecules. Fig. 1Structural, morphological and elemental characterization of AgNPs; (a) DLS graph of AgNPs indicating the hydrodynamic size of synthesized nanoparticles as 123 nm.; (b) HRTEM images showing nanoparticle size at scale of 200 nm with an inset showing image (at 10 nm scale) of ~ 15 ± 2 nm size of the nanoparticle, (c) electron diffraction pattern and (d) EDS spectrum representing the percentage of different elements present in AgNPs (the Inset shows a table of elemental composition). Structural, morphological and elemental characterization of AgNPs; (a) DLS graph of AgNPs indicating the hydrodynamic size of synthesized nanoparticles as 123 nm.; (b) HRTEM images showing nanoparticle size at scale of 200 nm with an inset showing image (at 10 nm scale) of ~ 15 ± 2 nm size of the nanoparticle, (c) electron diffraction pattern and (d) EDS spectrum representing the percentage of different elements present in AgNPs (the Inset shows a table of elemental composition). Selected Area Electron Diffraction (SAED) analysis (Fig. 1c) displayed distinct diffraction rings, confirming the crystalline nature of the synthesized AgNPs. Elemental composition was further verified by Energy Dispersive X-ray Spectroscopy (EDS), which confirmed the presence of elemental silver within the nanoformulation. Quantitative analysis indicated a silver content of 75.46% (Fig. 1d), validating successful incorporation of silver into the nanoparticle matrix. Spectroscopic analysis of nanoparticle formation UV–visible spectroscopy UV–visible spectroscopic analysis confirmed nanoparticle formation through characteristic surface plasmon resonance (SPR) behavior. The synthesized AgNPs exhibited a distinct absorption maximum at 426 nm with an absorbance of 0.462 (Fig. 2a), consistent with nanoscale silver particles. In comparison, native curcumin displayed a peak at 432 nm with significantly lower absorbance (0.063). The shift and enhancement in absorbance intensity following synthesis indicate successful reduction of Ag+ ions and nanoparticle formation mediated by curcumin. Fig. 2Characterization of AgNPs. (a) UV-visible absorption spectra showing the peak of AgNO3, pure Curcumin at ~ 432 nm and a peak at 426 nm for AgNPs, (b) FTIR spectra illustrating the interaction between AgNO3 (silver nitrate) and curcumin, which results in the formation of AgNPs, and (c) Raman providing us with the structural fingerprint by which different molecules can be defined. Characterization of AgNPs. (a) UV-visible absorption spectra showing the peak of AgNO3, pure Curcumin at ~ 432 nm and a peak at 426 nm for AgNPs, (b) FTIR spectra illustrating the interaction between AgNO3 (silver nitrate) and curcumin, which results in the formation of AgNPs, and (c) Raman providing us with the structural fingerprint by which different molecules can be defined. FTIR analysis Fourier Transform Infrared (FTIR) spectroscopy was performed to evaluate molecular interactions between curcumin and silver ions during nanoparticle formation (Fig. 2b; Table 1). A broad O–H stretching vibration was observed at 3424.43 cm−1 in AgNPs, suggesting involvement of hydroxyl groups in stabilization40,41. The bands at 2982.51 cm−1 (AgNO3), 2908.78 cm−1 (curcumin), and 2920 cm−1 (AgNPs) correspond to C–H stretching vibrations42–44 while additional C–H stretching appeared at 2858.19 cm−1 in AgNPs41,42. Curcumin exhibited a strong C=O stretching peak at 1751.27 cm−143, whereas shifts to 1639.52 cm−1 in AgNPs and 1684.98 cm−1 in curcumin indicate alterations in carbonyl and aromatic C=C environments following nanoparticle formation41,43. The band at 1521.81 cm−1 corresponds to combined C=O stretching and aromatic C–C vibrations, characteristic of the keto–enol tautomeric forms of curcumin42,43. Peaks at 1518–1520 cm−1 in AgNO3 and AgNPs are associated with symmetric NO stretching of nitrate species42. The presence of additional bands at 1370.05 cm−1 and 1394.33 cm−1 indicates contributions from N=O stretching and aromatic C=C vibrations, respectively41,43. Bands between 1275.20 cm−1 and 1046.70 cm−1 are attributed to C–O–C and C–O stretching modes45. These spectral shifts collectively confirm chemical interaction between curcumin functional groups and silver ions during nanoparticle formation. Table 1The table presents the wavenumber values obtained from FTIR (ranging from 400 to 4000 cm−1).Functional groupAgNO3CurAgNPsReferenceC–C–H bend731.97680.45678.0841–43=C–H wagging–889.51––C=C bending800.95––47C–O–C, C–N–1067.981046.7045C–O stretching1275.201241.35–45C=C bending–1394.331370.0541,43N–O stretching1518.80–1520.9542Aromatic C=C bending–1684.981639.5241,43.C=O stretching–1751.271521.81–42,43C–H stretching–2985.262858.1942–44HC=O: CH stretching2982.512908.78292047O–H stretching––3424.4340,41These values highlight changes in various functional groups, illustrating the interaction between AgNO3 (silver nitrate) and Curcumin, which results in the formation of AgNPs. Table 1The table presents the wavenumber values obtained from FTIR (ranging from 400 to 4000 cm−1).Functional groupAgNO3CurAgNPsReferenceC–C–H bend731.97680.45678.0841–43=C–H wagging–889.51––C=C bending800.95––47C–O–C, C–N–1067.981046.7045C–O stretching1275.201241.35–45C=C bending–1394.331370.0541,43N–O stretching1518.80–1520.9542Aromatic C=C bending–1684.981639.5241,43.C=O stretching–1751.271521.81–42,43C–H stretching–2985.262858.1942–44HC=O: CH stretching2982.512908.78292047O–H stretching––3424.4340,41These values highlight changes in various functional groups, illustrating the interaction between AgNO3 (silver nitrate) and Curcumin, which results in the formation of AgNPs. The table presents the wavenumber values obtained from FTIR (ranging from 400 to 4000 cm−1). 1751.27 1521.81 These values highlight changes in various functional groups, illustrating the interaction between AgNO3 (silver nitrate) and Curcumin, which results in the formation of AgNPs. Raman spectroscopic analysis Raman spectroscopy provided further structural confirmation of nanoparticle formation and molecular interactions (Fig. 2c; Table 2). The characteristic νC=O(II) stretching band of curcumin appeared at 1662.19 cm−146. Shifts in the carboxylic symmetric and antisymmetric C = O stretching vibrations were observed at 1543.94 cm−1 (curcumin) and 1578.34 cm−1 (AgNPs), indicating coordination effects46,47. In AgNPs, multiple bands at 1301.48, 1328.78, 1386.04, and 1409.48 cm−1 were observed. These bands are attributed to modified nitrate species resulting from Ag+–NO3− interactions, suggesting altered symmetry relative to free nitrate ions48. The appearance of new nitrate-related vibrational features indicates strong electrostatic and coordination interactions during nanoparticle formation. The enolic C–O stretching and antisymmetric C=O bands showed shifts from 1281.59 cm−1 (curcumin) to 1191.01 cm−1 (AgNPs)46,47 further supporting ligand–metal interaction. Vibrational bands between 957.86 and 1043.13 cm−1 in AgNPs correspond to symmetry-reduced nitrate species48, indicating structural perturbation upon silver coordination. Additional bands observed at 832.28 cm−1 (aromatic C–H out-of-plane bending) and 719.33–806.45 cm−1 (nitrate vibrational modes) further validate chemical interaction between curcumin and silver ions46,48. Low-frequency bands between 464.92 and 675.59 cm−1 are attributed to C–N–C stretching vibrations47, consistent with structural reorganization following nanoparticle formation. Collectively, the spectroscopic analyses confirm successful reduction of silver ions and stabilization of AgNPs through curcumin-mediated coordination and surface functionalization. Table 2The Raman spectra show wavenumbers in the range of 500–1800 cm−1 for AgNO3 (silver nitrate), Curcumin, and AgNPs, revealing the positions of various functional groups.Functional groupAgNO3CurAgNPsStretching vibration of C–N–C––464.92, 530.53, 552.58, 675.59v2 band, vibrational mode of nitrate ion719.33806.45–809.28CH out of plane bending of aromatic CCH and skeletal CCH–832.28–In-plane bending of CCH–957.86955.77symmetric bond between Ag + and NO3 ions ,In-plane bending of aromatic CCH and skeletal CCH,v1 band1043.131059.911058.72Enol C–O (II, III), C–O–C stretching,carboxylic symmetric–1183.21165.28Enol C–O(I) stretchinganti-symmetric C=O–1281.591191.01Nitrate ion1328.781409.46–1301.48, 1328.78, 1386.04,1409.48Phenol C–O stretching–1409.91–carboxylic symmetric and anti-symmetric C=Ostretching vibration of the carboxylic group–1543.941578.34ν C=O(II) stretching–1662.19–These values illustrate the interactions taking place, indicating the formation of AgNPs. Table 2The Raman spectra show wavenumbers in the range of 500–1800 cm−1 for AgNO3 (silver nitrate), Curcumin, and AgNPs, revealing the positions of various functional groups.Functional groupAgNO3CurAgNPsStretching vibration of C–N–C––464.92, 530.53, 552.58, 675.59v2 band, vibrational mode of nitrate ion719.33806.45–809.28CH out of plane bending of aromatic CCH and skeletal CCH–832.28–In-plane bending of CCH–957.86955.77symmetric bond between Ag + and NO3 ions ,In-plane bending of aromatic CCH and skeletal CCH,v1 band1043.131059.911058.72Enol C–O (II, III), C–O–C stretching,carboxylic symmetric–1183.21165.28Enol C–O(I) stretchinganti-symmetric C=O–1281.591191.01Nitrate ion1328.781409.46–1301.48, 1328.78, 1386.04,1409.48Phenol C–O stretching–1409.91–carboxylic symmetric and anti-symmetric C=Ostretching vibration of the carboxylic group–1543.941578.34ν C=O(II) stretching–1662.19–These values illustrate the interactions taking place, indicating the formation of AgNPs. The Raman spectra show wavenumbers in the range of 500–1800 cm−1 for AgNO3 (silver nitrate), Curcumin, and AgNPs, revealing the positions of various functional groups. 719.33 806.45 symmetric bond between Ag + and NO3 ions , In-plane bending of aromatic CCH and skeletal CCH, v1 band Enol C–O (II, III), C–O–C stretching, carboxylic symmetric Enol C–O(I) stretching anti-symmetric C=O 1328.78 1409.46 carboxylic symmetric and anti-symmetric C=O stretching vibration of the carboxylic group These values illustrate the interactions taking place, indicating the formation of AgNPs. Biological evaluation Cytotoxicity assessment The cytotoxic potential of the synthesized formulations was evaluated in AGS (human gastric adenocarcinoma) cells using the MTT assay. Cells were treated with AgNO3, curcumin, and AgNPs at concentrations of 10, 20, 40, 80, and 160 µg/mL. Untreated cells were considered 100% viable and used as the reference control. AgNO3 treatment resulted in cell viabilities of 99.81 ± 7.74%, 95.33 ± 19.01%, 84.36 ± 9.52%, 80.18 ± 7.04%, and 74.69 ± 2.13% across increasing concentrations. Curcumin reduced viability to 96.87 ± 8.96%, 87.58 ± 10.23%, 72.60 ± 8.19%, 72.51 ± 10.83%, and 61.13 ± 2.06%, respectively. Doxorubicin, a standard anticancer drug was also used to evaluate its toxicity impact on the AGS and it indicates the decrease in viability with increasing concentration from 91.49 ± 5.52%, 84.45 ± 13.47%, 70.71 ± 1.35%, 68.10 ± 8.31% and 55.11 ± 3.12%. In contrast, AgNPs treatment produced a markedly enhanced cytotoxic response, with cell viabilities declining to 92.22 ± 15.70%, 78.72 ± 4.02%, 68.38 ± 1.70%, 44.92 ± 3.84%, and 26.01 ± 2.13% at corresponding concentrations (Fig. 3). A clear concentration-dependent reduction in viability was observed for all treatments; however, AgNPs demonstrated the most pronounced cytotoxic effect, particularly at ≥ 80 µg/mL. On the other side, the HEK-293 cells when treated with same concentrations of AgNO3, curcumin, and AgNPs indicates that the cells remain viable even after treatment with the maximum concentration used of each compound indicating the enormous potential of synthesized nanoparticles as biocompatible and safe agents towards normal healthy cells. The data is shown in Fig. S1. and comparative quantitative data are provided in Table S1. Statistical significance was established at p < 0.05 and the data is given in Table S2. Fig. 3The MTT assay was used to assess the cytotoxicity of AgNPs on AGS cell line. The data depicts the treatment of AGS cells with control, including salt solution AgNO3, Curcumin, and AgNPs at concentrations of 10 µg/mL, 20 µg/mL, 40 µg/mL, 80 µg/mL, and 160 µg/mL. The MTT assay was used to assess the cytotoxicity of AgNPs on AGS cell line. The data depicts the treatment of AGS cells with control, including salt solution AgNO3, Curcumin, and AgNPs at concentrations of 10 µg/mL, 20 µg/mL, 40 µg/mL, 80 µg/mL, and 160 µg/mL. Cell migration assay The anti-migratory effect of the formulations was examined using a scratch wound assay at 160 µg/mL. Wound closure was quantified at 0, 6, 12, 24, and 48 h. Control cells exhibited progressive wound closure, with gap percentages decreasing to 33.76 ± 3.53% at 48 h, indicating near-complete migration. AgNO3-treated cells retained 40.59 ± 3.70% wound area at 48 h. Curcumin treatment resulted in 47.43 ± 5.08% residual gap. Notably, AgNPs-treated cells showed the greatest inhibition of migration, maintaining 53.41 ± 3.70% wound area after 48 h (Fig. 4). These findings demonstrate that AgNPs significantly impair AGS cell migratory capacity relative to control and individual components. Statistical analysis confirmed significance at p < 0.05 (Table S3). Fig. 4The diagram illustrates the impact of nanoparticles on inhibiting cancer cell migration in AGS cell line by the scratch assay. (a) 0 h, (b) 6 h, (c) 12 h, (d) 24 h, (e) 48 h are control cells, AgNO3 treated cells after (f) 0 h, (g) 6 h, (h) 12 h, (i) 24 h, (j) 48 h at a fixed concentration of 160 µg/mL, Cur treated cells after (k) 0 h, (l) 6 h, (m) 12 h, (n) 24 h, (o) 48 h with a concentration of 160 µg/mL, Cells treated with AgNPs after (p) 0 h, (q) 6 h, (r) 12 h, (s) 24 h, (t) 48 h with 160 µg/mL concentration, (u) Plot showing the comparison of the change in scratch width post treatment with Cur, AgNO3, and AgNPs including control after 0 h, 6 h, 12 h, 24 h, and 48 h. The diagram illustrates the impact of nanoparticles on inhibiting cancer cell migration in AGS cell line by the scratch assay. (a) 0 h, (b) 6 h, (c) 12 h, (d) 24 h, (e) 48 h are control cells, AgNO3 treated cells after (f) 0 h, (g) 6 h, (h) 12 h, (i) 24 h, (j) 48 h at a fixed concentration of 160 µg/mL, Cur treated cells after (k) 0 h, (l) 6 h, (m) 12 h, (n) 24 h, (o) 48 h with a concentration of 160 µg/mL, Cells treated with AgNPs after (p) 0 h, (q) 6 h, (r) 12 h, (s) 24 h, (t) 48 h with 160 µg/mL concentration, (u) Plot showing the comparison of the change in scratch width post treatment with Cur, AgNO3, and AgNPs including control after 0 h, 6 h, 12 h, 24 h, and 48 h. Antimicrobial activity Determination of minimum inhibitory concentration (MIC) Antibacterial efficacy was assessed using the broth dilution method. The MIC values were determined as 64 µg/mL for clarithromycin, 40 µg/mL for Helicobacter pylori and Acinetobacter calcoaceticus, and 80 µg/mL for Staphylococcus aureus (Fig. 5a; Fig. S2a-b). The comparatively higher MIC observed for S. aureus may be attributed to structural differences in bacterial cell wall architecture, which can influence nanoparticle penetration efficiency. Dose–response analysis yielded MIC₁₀, MIC2₀, and MIC50 values of 6.2, 5.66, and 3.86 µg/mL for H. pylori; 6.57, 5.82, and 3.55 µg/mL for A. calcoaceticus; and 7.82, 6.93, and 4.2 µg/mL for S. aureus, respectively. These results confirm substantial antibacterial activity of the synthesized nanoparticles across both Gram-negative and Gram-positive strains. Fig. 5(a) Depicting the H. pylori anti-bacterial activity performed with AgNO3, Cur and AgNPs using broth dilution method (b) Anti-bacterial activity via Agar well diffusion assay for H. pylori. FE-SEM micrographs at 500 nm of AgNPs treated H. pylori bacteria showing (c, d) untreated control bacteria (e, f) treated bacteria. (a) Depicting the H. pylori anti-bacterial activity performed with AgNO3, Cur and AgNPs using broth dilution method (b) Anti-bacterial activity via Agar well diffusion assay for H. pylori. FE-SEM micrographs at 500 nm of AgNPs treated H. pylori bacteria showing (c, d) untreated control bacteria (e, f) treated bacteria. Antibacterial activity by agar well diffusion assay The antibacterial efficacy of the synthesized AgNPs was further evaluated using the agar well diffusion method against both Gram-positive and Gram-negative strains. The zone of inhibition (ZOI) was measured following treatment with curcumin, penicillin–streptomycin (positive control), and AgNPs. For Acinetobacter calcoaceticus, the ZOI values were approximately 17.6 mm (curcumin), 18.8 mm (penicillin–streptomycin), and 21.4 mm (AgNPs). In the case of Staphylococcus aureus, the inhibition zones were 14.2 mm, 18.7 mm, and 20.3 mm, respectively (Fig. S2c-d). Similarly, for H. pylori, ZOI values of 17.4 mm (curcumin), 16.8 mm (clarithromycin), and 21.4 mm (AgNPs) were recorded (Fig. 5b and S2e). Across all tested strains, AgNPs demonstrated the largest inhibition zones, indicating superior antibacterial efficacy compared to curcumin and the standard antibiotic control. Field Emission Scanning Electron Microscopy (FE-SEM) images of treated H. pylori cells (Fig. 5c–f) revealed marked morphological alterations, further supporting nanoparticle-mediated bacterial disruption. Anti-urease activity The inhibitory effect of AgNPs on urease activity in H. pylori was evaluated in a concentration-dependent manner. Untreated bacterial samples were considered 100% active. Percentage inhibition increased progressively with concentration, reaching 6.48 ± 13.32%, 11.16 ± 12.22%, 21.08 ± 1.68%, 25.58 ± 2.48%, and 80.46 ± 1.15% at 10, 20, 40, 80, and 160 µg/mL, respectively (Fig. 6a). A marked increase in inhibition was observed at 160 µg/mL, indicating strong suppression of urease enzymatic activity. The calculated IC50 value was 5.31 µg/mL, demonstrating potent inhibitory capacity. These findings indicate that AgNPs effectively impair urease activity, a critical virulence factor in H. pylori, thereby contributing to reduced bacterial viability. Fig. 6(a) The graph represents the anti-urease activity of AgNPs against H. pylori. (b) Displays docking results of structure of Helicobacter pylori urease with docked curcumin within the ligand binding site (c) 2D (d) 3D interaction representation of curcumin (ligand) with the active site residues of Helicobacter pylori urease (PDB ID: 1E9Y), highlighting key binding interactions. (a) The graph represents the anti-urease activity of AgNPs against H. pylori. (b) Displays docking results of structure of Helicobacter pylori urease with docked curcumin within the ligand binding site (c) 2D (d) 3D interaction representation of curcumin (ligand) with the active site residues of Helicobacter pylori urease (PDB ID: 1E9Y), highlighting key binding interactions. Molecular docking analysis To gain deeper insights into the interaction between curcumin and the active sites of Helicobacter pylori urease, a molecular docking study was conducted (Fig. 6b). Nine distinct curcumin conformations were generated, each with distinct binding affinities. The pose with the most negative binding score was selected for further analysis, with a binding energy of − 6.9 kcal/mol, notably lower than that of the co-crystallised AHA ligand (− 4.2 kcal/mol). It was successfully docked into the target protein’s active site. Detailed interaction analysis showed that curcumin formed a hydrogen bond with ARG368 at a distance of 2.16 Å, and carbon-hydrogen bonds with HIS248, ASP362, and ALA365 at distances of 3.6 Å, 3.66 Å, and 3.74 Å, respectively. Additionally, hydrophobic interactions were observed with residues such as ALA169, CYS321, HIS221, HIS138, PRO302, and MET317, at distances of 4.43 Å, 5.38 Å, 5.48 Å, 5.04 Å, 4.63 Å, and 4.96 Å, respectively (Fig. 6c, d) Table 3). To verify the reliability of the docking results, the co-crystallised AHA ligand was re-docked into the protein’s active site, and the RMSD between the docked and native pose was calculated as 0.45 Å. The re-docking confirmed interactions with several key residues, including ASP362, HIS138, HIS221, ALA169, ALA365, MET366, ARG338, HIS274, HIS248, GLY279, and KCX219 (Fig. S3), validating that curcumin binds to the same active site as AHA. The data suggest that curcumin-protected nanoparticles exhibit potent inhibitory effects on Helicobacter pylori urease, highlighting their potential as effective therapeutic agents. Table 3Molecular docking results between ligands and protein.Name of the chemical structureDocking scoreTypes of interactionAmino acid is involved in the interaction with distanceAcetohydroxamic acid (AHA)− 4.4 kcal/molHydrogen BondCarbon-Hydrogen bondHydrophobic InteractionMetal-AcceptorASP362, KCX219, ARG338. (5.33,8.40,7.11 Å).HIS248.GLY279, HIS274, HIS138, HIS221, ALA169, ALA365 and MET366.NI3002, NI3001.Curcumin− 6.9 kcal/molHydrogen BondCarbon-Hydrogen bondHydrophobic InteractionARG368(2.16 Å).HIS248, ASP362, ALA365.ALA169, CYS321, HIS221, HIS138, PR0302 and MET317. Table 3Molecular docking results between ligands and protein.Name of the chemical structureDocking scoreTypes of interactionAmino acid is involved in the interaction with distanceAcetohydroxamic acid (AHA)− 4.4 kcal/molHydrogen BondCarbon-Hydrogen bondHydrophobic InteractionMetal-AcceptorASP362, KCX219, ARG338. (5.33,8.40,7.11 Å).HIS248.GLY279, HIS274, HIS138, HIS221, ALA169, ALA365 and MET366.NI3002, NI3001.Curcumin− 6.9 kcal/molHydrogen BondCarbon-Hydrogen bondHydrophobic InteractionARG368(2.16 Å).HIS248, ASP362, ALA365.ALA169, CYS321, HIS221, HIS138, PR0302 and MET317. Molecular docking results between ligands and protein. Hydrogen Bond Carbon-Hydrogen bond Hydrophobic Interaction Metal-Acceptor ASP362, KCX219, ARG338. (5.33,8.40,7.11 Å). HIS248. GLY279, HIS274, HIS138, HIS221, ALA169, ALA365 and MET366. NI3002, NI3001. Hydrogen Bond Carbon-Hydrogen bond Hydrophobic Interaction ARG368(2.16 Å). HIS248, ASP362, ALA365. ALA169, CYS321, HIS221, HIS138, PR0302 and MET317. Combination index analysis Synergistic interactions between AgNO3 and curcumin were evaluated using the combination index (CI) method. Dose–response parameters (Dm, m, and y) were derived from Fig. S4a–b, and CI values were calculated (Table S4). At 160 µg/mL, the CI value was 0.083, which is substantially less than 1, indicating strong synergism between AgNO3 and curcumin. These findings are consistent with enhanced cytotoxic and anti-migratory effects observed in vitro, suggesting cooperative interaction between the two agents in mediating anti-cancer activity. Conclusion Gastric cancer remains one of the most lethal malignancies worldwide, with a disproportionate burden in East Asia, South America, and parts of Eastern Europe. A central etiological driver is chronic infection with Helicobacter pylori, which colonizes nearly half of the global population and exceeds 60% prevalence in certain high-incidence regions. Beyond its carcinogenic classification as a Group I biological agent, H. pylori represent a substantial socio-economic challenge. The global cost of eradication therapy, repeated treatment failures, endoscopic surveillance, and management of advanced gastric cancer imposes a considerable financial burden on healthcare systems, particularly in low- and middle-income countries where antibiotic resistance is rapidly escalating. Clarithromycin- and metronidazole-resistant strains are now widely reported, with resistance rates exceeding 20–30% in several geographic regions, significantly compromising standard triple-therapy regimens and increasing recurrence rates. The emergence of efflux pump–mediated drug expulsion, β-lactamase production, and mutation-driven target modification underscores the urgent need for non-conventional antimicrobial strategies. Recent literature has increasingly recognized that gastric tumorigenesis is not solely a consequence of epithelial mutation but is profoundly shaped by the tumor-associated microbiome. Microbial dysbiosis within the tumor microenvironment (TME) can modulate immune surveillance, inflammatory signaling, angiogenesis, and metastatic potential. Studies linking Fusobacterium nucleatum and other microbial signatures to poor gastric cancer prognosis further reinforce the concept that targeting microbial persistence may represent an oncologically relevant intervention rather than merely an infectious disease strategy. Within this framework, the present study introduces curcumin-stabilized silver nanoparticles (AgNPs) as a microbiome-informed nanotherapeutic platform. From a nanomaterials perspective, the controlled synthesis of particles with a diameter of 15 ± 2 nm is of critical importance. This size regime optimizes surface-to-volume ratio, enhances catalytic reactivity, facilitates mucosal penetration, and promotes efficient cellular internalization. HR-TEM analysis confirmed uniform morphology, suggesting reproducible physicochemical properties essential for translational scalability. Mechanistically, the nanoformulation operates through multi-modal antimicrobial disruption. Silver ions interfere with thiol-containing enzymes and destabilize membrane integrity, while ROS generation induces oxidative damage to bacterial DNA, proteins, and lipids. Importantly, our findings demonstrate targeted inhibition of H. pylori urease activity, likely through disruption of the nickel-containing active site. Given that urease is indispensable for gastric colonization and acid neutralization, its inactivation directly compromises bacterial survival within the gastric niche. The multi-target oxidative and enzymatic interference inherent to AgNPs reduces the probability of resistance emergence compared to single-pathway antibiotics. Beyond antimicrobial activity, the nanoparticles exhibited significant cytotoxic and anti-migratory effects in AGS gastric adenocarcinoma cells. This dual functionality is mechanistically plausible: curcumin contributes redox modulation, NF-κB pathway suppression, and anti-inflammatory signaling, while silver nanoparticles amplify oxidative stress and mitochondrial dysfunction. The observed inhibition of cell migration suggests interference with cytoskeletal remodeling or matrix interaction pathways, implicating potential anti-metastatic relevance. Thus, the nanoformulation does not merely eradicate microbial drivers but directly attenuates tumor cell aggressiveness. From an oncology standpoint, this integrated approach addresses a critical translational gap: conventional therapies treat either infection or malignancy, rarely both in a coordinated manner. By targeting microbial virulence, inflammatory signaling, and tumor cell viability within the same microenvironmental context, AgNPs represent a systems-level intervention at the microbial–tumor interface. Economically, such a platform holds relevance for regions with high H. pylori prevalence and limited access to expensive multi-drug regimens. A stable, locally deliverable nanotherapeutic capable of reducing antibiotic reliance could lower recurrence rates, decrease treatment costs, and mitigate resistance escalation. Furthermore, the curcumin-based stabilization strategy leverages a bioactive phytochemical with established safety profiles, potentially facilitating regulatory translation. In conclusion, this study advances a nanomaterials-driven, microbiome-targeted paradigm for gastric cancer management. Curcumin-stabilized silver nanoparticles demonstrate mechanistic synergy, anti-urease specificity, antimicrobial resilience against resistance pathways, and concurrent anti-tumor activity. The key distinction of our work lies in the use of curcumin as a dual-function reducing and stabilizing agent, enabling a green, one-step synthesis approach without the need for additional toxic chemicals or external capping agents. Unlike conventional methods that rely on separate reducing and stabilizing systems, the present strategy integrates both functionalities within a single bioactive molecule, thereby simplifying the synthesis process and enhancing biocompatibility. Unlike general plant extracts, which are complex and compositionally variable, curcumin is a well-defined phytochemical with established pharmacological properties, including antioxidant and anticancer activities. In this study, curcumin serves a multifunctional role as a reducing agent, stabilizing/capping agent, and therapeutic moiety, enabling the formation of biofunctionalized silver nanoparticles in a controlled and reproducible manner. This eliminates the variability associated with crude plant extracts and provides better insight into structure–property–function relationships. In terms of physicochemical characteristics, the synthesized nanoparticles exhibit a small core size (~ 15 nm by TEM) with a curcumin-derived organic corona, which significantly influences their hydrodynamic behavior (~ 123 nm by DLS) and surface properties. This biofunctional coating differentiates our system from many previously reported AgNPs that are either uncoated or stabilized using synthetic polymers or surfactants. From a surface chemistry perspective, the presence of curcumin introduces biologically active functional groups (e.g., phenolic and keto–enol moieties), which not only stabilize the nanoparticles but also contribute to enhanced interaction with cellular systems. This contrasts with conventional AgNPs that lack intrinsic therapeutic functionality in their capping layer. Importantly, the biological performance of the curcumin-mediated AgNPs is expected to be synergistically enhanced due to the combined effects of silver-induced cytotoxicity and the well-documented bioactivity of curcumin, including its antioxidant and anticancer properties. This dual functionality provides an added advantage over previously reported systems that rely solely on the metallic core for activity. Future investigations should prioritize in vivo pharmacokinetics, mucosal retention studies, immunomodulatory profiling, and long-term toxicity evaluation to validate clinical feasibility. By bridging nanotechnology, microbiology, and oncology, this work contributes a strategically integrated approach to combating infection-driven malignancy in a globally impactful disease. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1